Knizetova et al proved that VEGFR2 is predominantly expressed on the cell surface of CD133+ human GSCs (glioma stem cells), whose viability, self-renewal, and tumorigenicity depend on signaling through the VEGF-VEGFR2-neuropilin-1 (NRP1) axis.35 This evidence concerns the gene NRP1 and central nervous system cancer.